GDR vs. AGL, YGEN, ABDX, PRM, VRCI, GENI, DMTR, LLAI, LLA, and IDHC
Should you be buying genedrive stock or one of its competitors? The main competitors of genedrive include ANGLE (AGL), Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), Verici Dx (VRCI), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.
genedrive vs.
ANGLE (LON:AGL) and genedrive (LON:GDR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability, community ranking and risk.
genedrive has lower revenue, but higher earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.
ANGLE has a net margin of -890.91% compared to genedrive's net margin of -1,412.18%. ANGLE's return on equity of -76.01% beat genedrive's return on equity.
18.8% of ANGLE shares are held by institutional investors. Comparatively, 0.3% of genedrive shares are held by institutional investors. 16.2% of ANGLE shares are held by insiders. Comparatively, 14.8% of genedrive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
ANGLE has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500. Comparatively, genedrive has a beta of -0.04, indicating that its stock price is 104% less volatile than the S&P 500.
In the previous week, ANGLE's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.
genedrive received 59 more outperform votes than ANGLE when rated by MarketBeat users. Likewise, 72.67% of users gave genedrive an outperform vote while only 62.46% of users gave ANGLE an outperform vote.
ANGLE presently has a consensus price target of GBX 40, suggesting a potential upside of 321.94%. Given ANGLE's stronger consensus rating and higher possible upside, equities research analysts plainly believe ANGLE is more favorable than genedrive.
Summary
ANGLE beats genedrive on 11 of the 16 factors compared between the two stocks.
Get genedrive News Delivered to You Automatically
Sign up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
genedrive Competitors List
Related Companies and Tools
This page (LON:GDR) was last updated on 4/19/2025 by MarketBeat.com Staff
Buy GDR Stock Free GDR Stock Alerts